期刊文献+

玻璃体切割手术对糖尿病患者血糖的影响 被引量:7

The effect of vitrectomy on blood sugar in diabetic patients
原文传递
导出
摘要 目的 评价糖尿病患者玻璃体切割手术后血糖变化 ,并分析有关影响因素。 方法 选择接受玻璃体切割手术的II型糖尿病患者 19例 ,测定术前、术后 1~ 2h、1、3、5d空腹血糖。用方差分析、t检验和相关回归分析方法分析术后血糖变化及其与术前基础血糖水平、糖尿病病程、手术时间及术中强化麻醉的相关性。 结果 糖尿病患者玻璃体切割手术后血糖显著高于术前 ,术后 1~ 2h达高峰 ,后逐渐下降(P <0 .0 5 ) ,至 5d基本接近术前水平 (P >0 .0 5 )。血糖升高与手术时间、术前基础血糖水平及糖尿病病程呈正相关 (P <0 .0 5 ) ,与术中强化麻醉有关。 结论 糖尿病患者玻璃体切割手术后血糖变化存在着先升高 ,至 5d左右趋于术前水平的规律。术后血糖变化主要影响因素为术前基础血糖水平、糖尿病病程、手术时间及术中强化麻醉。 Objective To evaluate the change of blood sugar in diabetic patients after vitrectomy and analyze the relative reasons. Methods Nineteen diabetes II patients (20 eyes) who underwent vitrectomies received the tests of blood sugar preoperatively, and 1~2 hours, 1, 3, and 5 days postoperatively. Analysis of variance, a paired Student's t-test, and correlation analysis were used to analyze the change of postoperative blood sugar and correlation between postoperative blood sugar change and its relative factors. Results Postoperative blood sugar increased significantly compared with the preoperative one (P< 0.05), reached the peak 1~2 hours postoperatively, and reached almost the preoperative level 5 days postoperatively (P>0.05). There was a positive correlation between blood sugar increase and operation time, preoperative blood sugar level, and diabetic duration (P<0.05). Postoperative blood sugar was relative to potentiated anesthesia. Conclusion There is a regularity that blood sugar increases just postoperatively and reaches the preoperative level 5 days postoperatively. The relative factors to blood sugar change include preoperative blood sugar level, diabetic duration, operation time, and potentiated anesthesia.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2000年第3期157-159,共3页 Chinese Journal of Ocular Fundus Diseases
关键词 糖尿病视网膜病变 玻璃体切除术 副作用 血糖 Diabetic retinopathy Diabetes mellitus Vitrectomy /adverse effects Blood glucose
  • 相关文献

参考文献2

  • 1尹伯元,临床内分泌学,1993年,416页
  • 2向红丁(译),国外医学.内科学分册,1988年,15卷,245页

同被引文献38

  • 1高立新,张薇.增殖性糖尿病视网膜病变的玻璃体手术治疗[J].中国实用眼科杂志,2005,23(1):55-58. 被引量:37
  • 2仝小林,李洪皎,段军.仝小林:血糖难控因素的中医辨识和治疗[J].糖尿病新世界,2005(2):13-14. 被引量:3
  • 3中华医学会眼科学会眼底病学组.糖尿病视网膜病变分期标准[J].眼底病,1985,1:42-42.
  • 4Smiddy WE,Flynn HW.Vitrectomy in the management of diabetic retinopathy.Surv Ophthalmol,1999,43:491-507.
  • 5Funatsu H,Yamashita H,Nakanishi H,et al.Angioteusin Ⅱ and vascular endothelial growth factor in the vitreous fluid of patients with proliferative disbetic retinopathy.Brit J Ophthalmol,2002,86:311-315.
  • 6Funatsu H,Yamashita H,Noma H,et al.Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin Ⅱ.Br J Ophthalmol,2004,88:1064-1068.
  • 7Abu El-Asrar AM,Van Damme J,Put W,et al.Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.Am J Ophthalmol,1997,123:599-606.
  • 8Kon CH,Occleston NL,Aylward GW,et al.Expression of vitreous cytokines in proliferative vitreoretinopathy.A prospective study.Invest Ophthalmol Vis Sci,1999,40:705-712.
  • 9Kempen JH, Colmain BJ,Leske MC, Haffner SM,et al. Eye Diseases Prevenlenee Research Group. The prevenlenee of diabetic retinopathy among adults in the untied states[ J ]. Arch Ophthalmol, 2004,122 : 552 - 563.
  • 10Lahey JM, Francis RR, Keamey JJ, et al. Combining phacoemulsification and vitrectomy in patients with proliferative diabetic retinopathy [ J]. Curr Opin Ophthalmol, 2004, 15: 192- 196.

引证文献7

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部